1. Home
  2. BNTC vs MBI Comparison

BNTC vs MBI Comparison

Compare BNTC & MBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • MBI
  • Stock Information
  • Founded
  • BNTC 1995
  • MBI 1973
  • Country
  • BNTC United States
  • MBI United States
  • Employees
  • BNTC N/A
  • MBI N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • MBI Property-Casualty Insurers
  • Sector
  • BNTC Health Care
  • MBI Finance
  • Exchange
  • BNTC Nasdaq
  • MBI Nasdaq
  • Market Cap
  • BNTC 339.8M
  • MBI 278.8M
  • IPO Year
  • BNTC N/A
  • MBI 1987
  • Fundamental
  • Price
  • BNTC $16.47
  • MBI $5.46
  • Analyst Decision
  • BNTC Strong Buy
  • MBI Buy
  • Analyst Count
  • BNTC 7
  • MBI 2
  • Target Price
  • BNTC $24.43
  • MBI $6.75
  • AVG Volume (30 Days)
  • BNTC 37.6K
  • MBI 450.4K
  • Earning Date
  • BNTC 05-12-2025
  • MBI 05-08-2025
  • Dividend Yield
  • BNTC N/A
  • MBI N/A
  • EPS Growth
  • BNTC N/A
  • MBI N/A
  • EPS
  • BNTC N/A
  • MBI N/A
  • Revenue
  • BNTC N/A
  • MBI $27,000,000.00
  • Revenue This Year
  • BNTC N/A
  • MBI N/A
  • Revenue Next Year
  • BNTC N/A
  • MBI N/A
  • P/E Ratio
  • BNTC N/A
  • MBI N/A
  • Revenue Growth
  • BNTC N/A
  • MBI 285.71
  • 52 Week Low
  • BNTC $4.75
  • MBI $3.22
  • 52 Week High
  • BNTC $15.97
  • MBI $7.46
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 66.94
  • MBI 42.19
  • Support Level
  • BNTC $14.90
  • MBI $4.93
  • Resistance Level
  • BNTC $15.97
  • MBI $5.69
  • Average True Range (ATR)
  • BNTC 1.03
  • MBI 0.32
  • MACD
  • BNTC 0.30
  • MBI 0.02
  • Stochastic Oscillator
  • BNTC 79.02
  • MBI 55.60

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About MBI MBIA Inc.

MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.

Share on Social Networks: